A profile of delafloxacin in the treatment of adults with community-acquired bacterial pneumonia.

Inmaculada López Montesinos Elena Sendra Juan Pablo Horcajada

Published in: Expert review of clinical pharmacology (2022)

and in patients with suspected or documented pneumonia due to MRSA. In post-influenza staphylococcal bacterial pneumonia, MRSA could be also considered an important pathogen.

Keyphrases

methicillin resistant staphylococcus aureus
staphylococcus aureus
respiratory failure
community acquired pneumonia
mental health
acute respiratory distress syndrome